FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2001323802> ?p ?o ?g. }

• W2001323802 endingPage "187" @default.
• W2001323802 startingPage "178" @default.
• W2001323802 abstract "Heart failure in blacks has been associated with a poorer prognosis than in whites. In such diseases as hypertension, blacks show pathophysiological differences and respond differently to some therapies than whites. The aim of this study is to evaluate the clinical characteristics and response to therapy of black compared with white patients with heart failure.In the first Vasodilator-Heart Failure Trial (V-HeFT I), 180 black male patients were compared with 450 white male patients for baseline characteristics, prognosis, and response to therapy. In V-HeFT II, the same comparisons were made for 215 black and 574 white male patients, including an analysis stratified by the presence or absence of a history of hypertension. In both trials, black patients had a lower incidence of coronary artery disease, greater incidence of previous hypertension, and a greater cardiothoracic ratio (P < .05) than white patients. In V-HeFT II, plasma norepinephrine levels were significantly less in blacks; plasma renin activity was less only in blacks with a history of hypertension. Overall mortality or hospitalization for congestive heart failure did not differ between blacks and whites in the placebo group in V-HeFT I. However, the mortality of black patients receiving hydralazine plus isosorbide dinitrate (H-I) was reduced (P = .04) in V-HeFT I, whereas white patients showed no difference from placebo. In V-HeFT II, only white patients showed a mortality reduction from enalapril therapy compared with H-I therapy (P = .02). Whites also showed evidence of greater blood pressure reduction and enhanced regression of cardiac size in response to enalapril. When stratified by history of hypertension in V-HeFT II, only whites with a history of hypertension, who had greater renin levels, showed significant mortality reduction with enalapril compared with H-I therapy. Hospitalization rates did not differ between treatment groups in either study.Whites and blacks showed differences in cause, neurohormonal stimulation, and pharmacological response in heart failure. This retrospective analysis suggests angiotensin-converting enzyme inhibitors are particularly effective in whites, and the H-I combination can be equally effective in blacks. Prospective trials involving large numbers of black patients are needed to further clarify their response to therapy." @default.
• W2001323802 created "2016-06-24" @default.
• W2001323802 creator A5014867782 @default.
• W2001323802 creator A5018464718 @default.
• W2001323802 creator A5039697719 @default.
• W2001323802 creator A5057334801 @default.
• W2001323802 date "1999-09-01" @default.
• W2001323802 modified "2023-10-14" @default.
• W2001323802 title "Racial differences in response to therapy for heart failure: Analysis of the vasodilator-heart failure trials" @default.
• W2001323802 cites W1827617621 @default.
• W2001323802 cites W1970288923 @default.
• W2001323802 cites W1979390611 @default.
• W2001323802 cites W1997471839 @default.
• W2001323802 cites W2043691844 @default.
• W2001323802 cites W2046383587 @default.
• W2001323802 cites W2052155376 @default.
• W2001323802 cites W2059407166 @default.
• W2001323802 cites W2060633147 @default.
• W2001323802 cites W2083304301 @default.
• W2001323802 cites W2087436837 @default.
• W2001323802 cites W2103977786 @default.
• W2001323802 cites W2128278433 @default.
• W2001323802 cites W2145422631 @default.
• W2001323802 cites W2157973908 @default.
• W2001323802 cites W2334387759 @default.
• W2001323802 cites W3151135597 @default.
• W2001323802 cites W4238012364 @default.
• W2001323802 cites W4240751654 @default.
• W2001323802 cites W4241781783 @default.
• W2001323802 cites W4244946037 @default.
• W2001323802 cites W4251684463 @default.
• W2001323802 doi "https://doi.org/10.1016/s1071-9164(99)90001-5" @default.
• W2001323802 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10496190" @default.
• W2001323802 hasPublicationYear "1999" @default.
• W2001323802 type Work @default.
• W2001323802 sameAs 2001323802 @default.
• W2001323802 citedByCount "471" @default.
• W2001323802 countsByYear W20013238022012 @default.
• W2001323802 countsByYear W20013238022013 @default.
• W2001323802 countsByYear W20013238022014 @default.
• W2001323802 countsByYear W20013238022015 @default.
• W2001323802 countsByYear W20013238022016 @default.
• W2001323802 countsByYear W20013238022017 @default.
• W2001323802 countsByYear W20013238022018 @default.
• W2001323802 countsByYear W20013238022019 @default.
• W2001323802 countsByYear W20013238022020 @default.
• W2001323802 countsByYear W20013238022021 @default.
• W2001323802 countsByYear W20013238022022 @default.
• W2001323802 countsByYear W20013238022023 @default.
• W2001323802 crossrefType "journal-article" @default.
• W2001323802 hasAuthorship W2001323802A5014867782 @default.
• W2001323802 hasAuthorship W2001323802A5018464718 @default.
• W2001323802 hasAuthorship W2001323802A5039697719 @default.
• W2001323802 hasAuthorship W2001323802A5057334801 @default.
• W2001323802 hasConcept C120665830 @default.
• W2001323802 hasConcept C121332964 @default.
• W2001323802 hasConcept C126322002 @default.
• W2001323802 hasConcept C142724271 @default.
• W2001323802 hasConcept C164705383 @default.
• W2001323802 hasConcept C204787440 @default.
• W2001323802 hasConcept C27016395 @default.
• W2001323802 hasConcept C27081682 @default.
• W2001323802 hasConcept C2775940317 @default.
• W2001323802 hasConcept C2778198053 @default.
• W2001323802 hasConcept C2778949068 @default.
• W2001323802 hasConcept C2780521442 @default.
• W2001323802 hasConcept C61511704 @default.
• W2001323802 hasConcept C71924100 @default.
• W2001323802 hasConcept C84393581 @default.
• W2001323802 hasConceptScore W2001323802C120665830 @default.
• W2001323802 hasConceptScore W2001323802C121332964 @default.
• W2001323802 hasConceptScore W2001323802C126322002 @default.
• W2001323802 hasConceptScore W2001323802C142724271 @default.
• W2001323802 hasConceptScore W2001323802C164705383 @default.
• W2001323802 hasConceptScore W2001323802C204787440 @default.
• W2001323802 hasConceptScore W2001323802C27016395 @default.
• W2001323802 hasConceptScore W2001323802C27081682 @default.
• W2001323802 hasConceptScore W2001323802C2775940317 @default.
• W2001323802 hasConceptScore W2001323802C2778198053 @default.
• W2001323802 hasConceptScore W2001323802C2778949068 @default.
• W2001323802 hasConceptScore W2001323802C2780521442 @default.
• W2001323802 hasConceptScore W2001323802C61511704 @default.
• W2001323802 hasConceptScore W2001323802C71924100 @default.
• W2001323802 hasConceptScore W2001323802C84393581 @default.
• W2001323802 hasIssue "3" @default.
• W2001323802 hasLocation W20013238021 @default.
• W2001323802 hasLocation W20013238022 @default.
• W2001323802 hasOpenAccess W2001323802 @default.
• W2001323802 hasPrimaryLocation W20013238021 @default.
• W2001323802 hasRelatedWork W1173505 @default.
• W2001323802 hasRelatedWork W2008560208 @default.
• W2001323802 hasRelatedWork W2020048076 @default.
• W2001323802 hasRelatedWork W2064835951 @default.
• W2001323802 hasRelatedWork W2373841984 @default.
• W2001323802 hasRelatedWork W2413883100 @default.
• W2001323802 hasRelatedWork W2463695484 @default.
• W2001323802 hasRelatedWork W2481342343 @default.
• W2001323802 hasRelatedWork W2561798703 @default.

• next